Application
Western blot analysis of extracts from Hela cells using FKHR(Ab-256) AntibodyApplication
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using FKHR Antibody (left) or the same antibody preincubated with blocking peptide (right).Application
Immunofluorescence staining of methanol-fixed Hela cells using FKHR Antibody .Application
Western blot analysis of extracts from Hela cells using FKHR Antibody .| Product Name | FOXO1 antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit polyclonal antibody to FOXO1FKHR belongs to the forkhead family of transcription factors, which are characterized by a distinct forkhead domain. It may play a role in myogenic growth and differentiation. The mammalian DAF-16-like transcription factors, FKHR, FKHRL1, and AFX, function as key regulators of insulin signaling, cell cycle progression, and apoptosis downstream of phosphoinositide 3-kinase. Gene activation through binding to insulin response sequences has been essential for mediating these functions. D-type Cyclins (in Class III) is required for FKHR mediated inhibition of cell cycle progression and transformation. FKHR gene is mapped to chromosome 13q14 |
| Immunogen | Peptide sequence around aa.254~258 (A-A-S-M-D) derived from Human FKHR/FOXO1A. |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | ICC/IFIHC-PWB |
| Suggested starting dilutions are as follows. WB: 1:500~1:1000, IHC-P: 1:50~1:100, ICC/IF: 1:100~1:200. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.: |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml (Please refer to the vial label for the specific concentration) |
| Purification | Affinity purified |
| Gene Synonyms | FKH1 FKHR FOXO1A FOXO1 forkhead Drosophila homolog of in rhabdomyosarcoma forkhead box protein O1 forkhead box protein O1A forkhead box O1 |
|---|---|
| Target | FOXO1 |
| Molecular Weight(MW) | 78-82 (note) |
Application
Western blot analysis of extracts from Hela cells using FKHR(Ab-256) Antibody
Application
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using FKHR Antibody (left) or the same antibody preincubated with blocking peptide (right).
Application
Immunofluorescence staining of methanol-fixed Hela cells using FKHR Antibody .
Application
Western blot analysis of extracts from Hela cells using FKHR Antibody .| Application Notes | Suggested starting dilutions are as follows. WB: 1:500~1:1000, IHC-P: 1:50~1:100, ICC/IF: 1:100~1:200. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.: |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Keep as concentrated solution. Aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
